Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome)

International Journal of Cancer. Journal International Du Cancer
H LynchJ F Lynch

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) predisposes to cancers of the colon, endometrium and several other extra-colonic sites in the absence of premonitory physical stigmata (Muir-Torre syndrome excepted). Discovery of the several DNA mismatch repair genes (hMSH2, hMLH1, hPMS1, hPMS2) holds the potential for determining the cancer destiny of patients, theoretically in utero. Pre-symptomatic DNA testing is now possible in patients from HNPCC families and will be clinically available once inexpensive and simple tests for these germ-line mutations have been effected. Genetic counseling will be mandatory, given the myriad socio-psychological, insurance, and potentially other personal issues which may impact this knowledge. New findings in the pathology of HNPCC, particularly an increased frequency of interval cancers and the likely accelerated rate of the adenoma to cancer sequence, indicate the need for more frequent colonoscopic surveillance with an option for prophylactic subtotal colectomy in germ-line-positive individuals.

References

Nov 1, 1992·Medical Care·R B Kelly, J C Shank
Jan 1, 1992·Journal of the National Cancer Institute·K M KashD G Miller
Jul 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LermanP F Engstrom
Sep 1, 1988·The New England Journal of Medicine·L A Cannon-AlbrightR W Burt
Apr 20, 1988·Journal of the National Cancer Institute·H T LynchH D Appelman
Jan 1, 1987·Preventive Medicine·S J BlalockR S Sandler
Dec 1, 1986·The American Journal of Medicine·H T LynchJ F Lynch
Mar 1, 1986·Diseases of the Colon and Rectum·J P Mecklin, H J Järvinen
Jul 15, 1982·Cancer·W A AlbanoW J Kimberling
Mar 30, 1995·The New England Journal of Medicine·S R HamiltonB Tetu
Jun 1, 1995·Diseases of the Colon and Rectum·J P MecklinJ Tulikoura
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·M Nyström-LahtiP Peltomäki
Apr 15, 1994·American Journal of Medical Genetics·N F Sharpe
Dec 30, 1993·The New England Journal of Medicine·S J WinawerJ F Panish
Mar 1, 1993·Journal of General Internal Medicine·B D McCarthy, M A Moskowitz
May 7, 1993·Science·L A AaltonenS R Hamilton
May 7, 1993·Science·S N ThibodeauD Schaid
Jun 1, 1993·Medical Care·R E MyersL Millner
Jul 7, 1993·Journal of the National Cancer Institute·C LermanP Engstrom

❮ Previous
Next ❯

Citations

Oct 14, 2003·The Lancet Oncology·Marc PocardPhilippe Lasser
Apr 30, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J R JassB A Leggett
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·T L DeWeeseW G Nelson
Jan 1, 1997·Journal of Medical Genetics·I P TomlinsonW F Bodmer
May 8, 2001·Genetics in Medicine : Official Journal of the American College of Medical Genetics·UNKNOWN Joint Test and Technology Transfer Committee Working Group, American College of Medical Genetics, 9650 Rockville Pike, Bethe
Sep 18, 2002·Gut·B Leggett
Jun 20, 2008·Nature Reviews. Cancer·Chandan Kumar-SinhaArul M Chinnaiyan
Oct 3, 2008·The American Journal of Surgical Pathology·Joel K GreensonStephen B Gruber
Aug 7, 2009·Human Genetics·Anya N MilneG J A Offerhaus
Jul 10, 1998·Japanese Journal of Clinical Oncology·K KonishiR Makino
Jul 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H F A VasenUNKNOWN ESMO Guidelines Working Group
Jun 19, 2013·Expert Opinion on Drug Discovery·Joshua C Curtin
Apr 20, 2013·American Journal of Preventive Medicine·Driss Ait OuakrimMark A Jenkins
Mar 1, 2012·Clinics and Research in Hepatology and Gastroenterology·Ki Joo KangYoung-Ho Kim
Jul 6, 2010·Trends in Pharmacological Sciences·Bastiaan EversJos Jonkers
Oct 28, 2009·Clinical Lymphoma & Myeloma·Ayşen TimurağaoğluEvren Kiriş
Jul 14, 1999·The American Journal of Medicine·J L IvanovichA J Whelan
Feb 20, 2002·The Journal of Investigative Dermatology·Ester AlvinoStefania D'Atri
Sep 9, 2008·Critical Reviews in Oncology/hematology·Peh Yean Cheah
Jul 17, 2007·Gastroenterology·Mark A JenkinsUNKNOWN Colon Cancer Family Registry
Sep 25, 2009·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Ingeborg B EngelsenHelga B Salvesen
Mar 27, 2007·The Journal of Pathology·J-M MosqueraM A Rubin
Nov 26, 2009·Chemistry : a European Journal·Anton GranzhanMarie-Paule Teulade-Fichou
Nov 16, 2004·Mutation Research·Chandrajit P RautMiguel A Rodriguez-Bigas
Jun 10, 2004·Human Pathology·Jaime Prat
Oct 25, 2000·The Journal of the American Association of Gynecologic Laparoscopists·P A Argenta, F Nezhat
Jul 2, 2005·Gastrointestinal Endoscopy Clinics of North America·Yuki Young, Jonathan P Terdiman
Aug 1, 1997·Hematology/oncology Clinics of North America·T C Hoops, P G Traber
Mar 1, 1997·Gastroenterology Clinics of North America·A M Codori
Mar 8, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·R Plummer
Apr 4, 2015·Gastrointestinal Endoscopy Clinics of North America·Joep Evert Godfried IJspeertEvelien Dekker
Oct 18, 1996·Cell·K W Kinzler, B Vogelstein
Dec 4, 2014·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·G H LeeS K Clark
Dec 18, 2001·Genes, Chromosomes & Cancer·Marta Szadkowski, Josef Jiricny
Aug 26, 1998·The Journal of Pathology·N J Toft, M J Arends
Jan 1, 1997·Human Mutation·N Papadopoulos, A Lindblom

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.